(19)
(11) EP 1 841 406 A2

(12)

(88) Date of publication A3:
19.04.2007

(43) Date of publication:
10.10.2007 Bulletin 2007/41

(21) Application number: 05854851.2

(22) Date of filing: 20.12.2005
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
(86) International application number:
PCT/US2005/046204
(87) International publication number:
WO 2006/069079 (29.06.2006 Gazette 2006/26)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK YU

(30) Priority: 21.12.2004 US 637824 P

(71) Applicant: SMITHKLINE BEECHAM CORPORATION
Philadelphia, PA 19101 (US)

(72) Inventors:
  • BLAKE, Simon M.
    Malvern, PA 19355 (US)
  • MILLER, William Henry
    Collegeville, PA 19426 (US)
  • SAYANI, Amyn
    Mississauga, Ontario L5N 6L4 (CA)
  • WILKENS, H. Jeffrey
    King Of Prussia, PA 19406 (US)

(74) Representative: Goddard, Carolyn Janice et al
GlaxoSmithKline Corporate Intellectual Property (CN925.1) 980 Great West Road Brentford
Middlesex TW8 9GS
Middlesex TW8 9GS (GB)

   


(54) METHODS AND FORMULATIONS